Table 2.
Patient characteristics and laboratory parameters at the study inclusion
|
Arm A (n = 9) |
Arm B (n = 7) |
pvalue | |
|---|---|---|---|
| Patients’ characteristics | (m + SE) | (m + SE) | |
| Age | 36.3 ± 6.70 | 34.7 ± 6.92 | 0.643 |
| Sex | |||
| Male | 6 (75.0) | 2 (25.0) | 0.131 |
| Female | 3 (37.5) | 5 (62.5) | |
| Weight (kg) | 53.2 ± 8.43 | 49.1 ± 8.93 | 0.367 |
| Body mass index (BMI) | 18.6 ± 3.08 | 16.5 ± 2.88 | 0.182 |
| Haemoglobin (g/dL) | 8.4 ± 1.95 | 11.1 ± 3.51 | 0.062 |
| Leucocytes (103/mL)) | 5277 ± 5385 | 5928 ± 3304 | 0.783 |
| Neutrophils (103/mL)) | 3795 ± 3663 | 3638 ± 3134 | 0.929 |
| Lymphocyte (103/mL)) | 2417 ± 2224 | 1442 ± 485 | 0.277 |
| Monocytes (103/mL)) | 400 ± 430 | 271 ± 179 | 0.472 |
| AST (U/L) | 46.5 ± 24.23 | 48.2 ± 33.10 | 0.905 |
| ALT (U/L) | 41.2 ± 25.43 | 32.8 ± 22.05 | 0.500 |
| Creatinine (μmol/L) | 98.2 ± 22.04 | 93.1 ± 21.96 | 0.652 |
| Total cholesterol (mmol/L) T | 143.2 ± 30.30 | 129.8 ± 25.91 | 0.368 |
| HDL cholesterol (mmol/L) | 44.7 ± 23.63 | 42.4 ± 16.84 | 0.827 |
| Amylase (U/L) | 131.0 ± 71.31 | 92.8 ± 53.28 | 0.266 |
| Total bilirubin (μmol/L) | 3.3 ± 2.26 | 3.8 ± 2.33 | 0.696 |
| Direct bilirubin (μmol/L) | 1.08 ± 0.85 | 1.45 ± 1.56 | 0.618 |
| Lymphocytes CD4+ T (cells/μL) | 221.1 ± 154.75 | 285.8 ± 175.39 | 0.446 |
| Type of tuberculosis | |||
| SPPT | 7 (50.0) | 7 (50.0) | 0.475 |
| SNPT | 2 (100.0) | 0 (0.0) | – |
| WHO HIV stage | |||
| Stage 2 | 1/9 | 0/7 | 0.562 |
| Stage 3 | 8/9 | 7/7 | |
| Opportunistic infections | |||
| Yes | 5/9 | 3/7 | 0.500 |
| No | 4/9 | 4/7 | |